Vascular Biology |
From the Division of Cardiovascular Research (D.C., K.W., J.W.), St. Elizabeths Medical Center, Tufts University School of Medicine, Boston, Mass; and the Cardiovascular Division (J.W.), Lilly Research Labs, Eli Lilly and Company, Indianapolis, Ind.
Correspondence to Jian Wang, PhD, Eli Lilly and Company, Mail Drop 0434, Lilly Corporate Center, Indianapolis, IN 46285. E-mail: wang_jian{at}lilly.com
AbstractEndothelial cells (ECs) are quiescent in normal blood vessels but undergo rapid bursts of proliferation after vascular injury and during angiogenesis. Here we show that the activity of cyclin-dependent kinase-2 (cdk2), a key regulator of the G1 and S phases of the cell cycle, is expressed at high levels in proliferating ECs but at low levels in ECs that are contact-inhibited for growth. Despite these differences in kinase activity, the protein levels of cdk2 and 1 of its activating subunits, cyclin E, are not modulated by these different growth conditions. The cdk inhibitor p27 is highly expressed in contact-inhibited but not proliferating ECs, whereas the level of cyclin A protein is preferentially expressed in proliferating ECs. p27 protein was detected in immunoprecipitable complexes with cdk2 or cyclin E in cultures that were contact-inhibited for growth. The functional significance of the p27 induction was indicated by the detection of a heat-stable cdk2 inhibitory activity that was induced by endothelial cell-cell contact and could be immunodepleted with anti-p27 antibodies. In a confluent EC monolayer, cdk2 kinase activity was activated by a scraping injury that led to cell migration and proliferation. The injury-induced activation of cdk2 coincided with the downregulation of p27 and the induction of cyclin A. These data demonstrate that p27 is induced in confluent cultures of ECs. They also indicate that both p27 induction and cyclin A downregulation contribute to the inhibition of cdk2 and cell proliferation by cell-cell contact in ECs.
Key Words: cell cycle contact inhibition endothelium
This article has been cited by other articles:
![]() |
V. Solodushko and B. Fouty Proproliferative phenotype of pulmonary microvascular endothelial cells Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L671 - L677. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Herbert, S. Ponnambalam, and J. H. Walker Cytosolic Phospholipase A2-{alpha} Mediates Endothelial Cell Proliferation and Is Inactivated by Association with the Golgi Apparatus Mol. Biol. Cell, August 1, 2005; 16(8): 3800 - 3809. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vondracek, M. Machala, V. Bryja, K. Chramostova, P. Krcmar, C. Dietrich, A. Hampl, and A. Kozubik Aryl Hydrocarbon Receptor-Activating Polychlorinated Biphenyls and Their Hydroxylated Metabolites Induce Cell Proliferation in Contact-Inhibited Rat Liver Epithelial Cells Toxicol. Sci., January 1, 2005; 83(1): 53 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ezan, L. Leroux, L. Barandon, P. Dufourcq, B. Jaspard, C. Moreau, C. Allieres, D. Daret, T. Couffinhal, and C. Duplaa FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo Cardiovasc Res, September 1, 2004; 63(4): 731 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Andres Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res, July 1, 2004; 63(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Arkenbout, M. van Bragt, E. Eldering, C. van Bree, J. M. Grimbergen, P. H.A. Quax, H. Pannekoek, and C. J.M. de Vries TR3 Orphan Receptor Is Expressed in Vascular Endothelial Cells and Mediates Cell Cycle Arrest Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1535 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Favot, S. Martin, T. Keravis, R. Andriantsitohaina, and C. Lugnier Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis Cardiovasc Res, August 1, 2003; 59(2): 479 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Castro, A. Diez-Juan, M. J. Cortes, and V. Andres Distinct Regulation of Mitogen-activated Protein Kinases and p27Kip1 in Smooth Muscle Cells from Different Vascular Beds. A POTENTIAL ROLE IN ESTABLISHING REGIONAL PHENOTYPIC VARIANCE J. Biol. Chem., February 7, 2003; 278(7): 4482 - 4490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. GOUKASSIAN, A. DIEZ-JUAN, T. ASAHARA, P. SCHRATZBERGER, M. SILVER, T. MURAYAMA, J. M. ISNER, and V. ANDRES Overexpression of p27Kip1 by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis FASEB J, September 1, 2001; 15(11): 1877 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schonherr, B. Levkau, L. Schaefer, H. Kresse, and K. Walsh Decorin-mediated Signal Transduction in Endothelial Cells. INVOLVEMENT OF Akt/PROTEIN KINASE B IN UP-REGULATION OF p21WAF1/CIP1 BUT NOT p27KIP1 J. Biol. Chem., October 26, 2001; 276(44): 40687 - 40692. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |